Clinical trials

Condition   Drug Name  
Study Efalizumab in psoriasis
Design Randomized; Pooled/meta-analysis
Treatment Regimen Efalizumab; Placebo
Conclusions Results from phase III studies suggested that efalizumab had a favourable safety profile in patients with plaque psoriasis
Reference(s) Review of over 17 000 patient-years safety experience with efalizumab in patients with psoriasis
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P1105.
Author and Affiliation Kragballe, K., Curtin, F.